NCT02647866 - Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

October 31, 2018

Conditions

Ulcerative ColitisDigestive System DiseasesColitis, UlcerativeColitisGastrointestinal DiseasesInflammatory Bowel DiseasesIntestinal DiseasesColonic DiseasesAutoimmune DiseaseAbdominal Pain

Interventions

DRUG

KHK4083

IV Infusion

DRUG

Placebo

IV Infusion

Trial Locations (23)

1125

Budapest

11080

Zemun

Bežanija Kosa, Belgrade

29615

Greenville

129110

Moscow

194354

Saint Petersburg

196247

Saint Petersburg

440026

Penza

630091

Novosibirsk

660022

Krasnoyarsk

500 12

Hradec Králové

669 02

Znojmo

H-1032

Budapest

H-1083

Budapest

85-168

Bydgoszcz

35-302

Rzeszów

81-756

Sopot

43-100

Tychy

00-632

Warsaw

03-580

Warsaw

54-239

Warsaw

020125

Bucharest

34 000

Kragujevac